Jeffrey E. Russel

Array ( [id] => 5495830 [patent_doc_number] => 20090263858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Process for synthesis of mucin-type peptides and muc1-related glycopeptides' [patent_app_type] => utility [patent_app_number] => 11/663081 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 58339 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263858.pdf [firstpage_image] =>[orig_patent_app_number] => 11663081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343250 [patent_doc_number] => 20090181900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 11/575026 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17605 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181900.pdf [firstpage_image] =>[orig_patent_app_number] => 11575026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844322 [patent_doc_number] => 20060122113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/223408 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 28943 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122113.pdf [firstpage_image] =>[orig_patent_app_number] => 11223408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740553 [patent_doc_number] => 08106014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Methods and apparatus for enhanced growth of peripheral nerves and nervous tissue' [patent_app_type] => utility [patent_app_number] => 11/575268 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 9209 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106014.pdf [firstpage_image] =>[orig_patent_app_number] => 11575268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769003 [patent_doc_number] => 20060019876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Targeted delivery of bioaffecting compounds for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/212664 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11861 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019876.pdf [firstpage_image] =>[orig_patent_app_number] => 11212664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 816998 [patent_doc_number] => 07410806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use' [patent_app_type] => utility [patent_app_number] => 11/209185 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3797 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410806.pdf [firstpage_image] =>[orig_patent_app_number] => 11209185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721251 [patent_doc_number] => 20060074026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Therapeutic agents and methods for cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 11/198005 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20873 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074026.pdf [firstpage_image] =>[orig_patent_app_number] => 11198005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185310 [patent_doc_number] => 07645740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Peptide sequence found in Laminin 5 for treating skin impairments' [patent_app_type] => utility [patent_app_number] => 11/572774 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 36 [patent_no_of_words] => 11200 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645740.pdf [firstpage_image] =>[orig_patent_app_number] => 11572774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843618 [patent_doc_number] => 07387996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Formulations of insulin' [patent_app_type] => utility [patent_app_number] => 11/193200 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6240 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/387/07387996.pdf [firstpage_image] =>[orig_patent_app_number] => 11193200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710965 [patent_doc_number] => 20060052310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Regulation of substrate activity' [patent_app_type] => utility [patent_app_number] => 11/190487 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7347 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052310.pdf [firstpage_image] =>[orig_patent_app_number] => 11190487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494112 [patent_doc_number] => 20100009923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Antigens Targeted by Pathogenic Al4 T Cells in Type 1 Diabetes and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/658457 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29731 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009923.pdf [firstpage_image] =>[orig_patent_app_number] => 11658457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 848900 [patent_doc_number] => 07381416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics' [patent_app_type] => utility [patent_app_number] => 11/187617 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7820 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381416.pdf [firstpage_image] =>[orig_patent_app_number] => 11187617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232926 [patent_doc_number] => 20050256053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Combined use of a GLP-1 compound and another drug for treating dyslipidemia' [patent_app_type] => utility [patent_app_number] => 11/185209 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6313 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256053.pdf [firstpage_image] =>[orig_patent_app_number] => 11185209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368389 [patent_doc_number] => 20090305948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications' [patent_app_type] => utility [patent_app_number] => 11/658875 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305948.pdf [firstpage_image] =>[orig_patent_app_number] => 11658875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263781 [patent_doc_number] => 07569546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Apolipoprotein A1 mimetics and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/182490 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8566 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569546.pdf [firstpage_image] =>[orig_patent_app_number] => 11182490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607409 [patent_doc_number] => 07098307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Neo-tryptophan' [patent_app_type] => utility [patent_app_number] => 11/178269 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16651 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/098/07098307.pdf [firstpage_image] =>[orig_patent_app_number] => 11178269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439466 [patent_doc_number] => 07259145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Mechanically activated channel blocker' [patent_app_type] => utility [patent_app_number] => 11/176745 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4305 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259145.pdf [firstpage_image] =>[orig_patent_app_number] => 11176745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162581 [patent_doc_number] => 07671033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Amphiphilic dendritic dipeptides and their self-assembly into helical pores' [patent_app_type] => utility [patent_app_number] => 11/171494 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 41292 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671033.pdf [firstpage_image] =>[orig_patent_app_number] => 11171494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331253 [patent_doc_number] => 20090111730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Polypeptide protracting tags' [patent_app_type] => utility [patent_app_number] => 11/631889 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26611 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111730.pdf [firstpage_image] =>[orig_patent_app_number] => 11631889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681773 [patent_doc_number] => 20080247999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Treating Cancer' [patent_app_type] => utility [patent_app_number] => 11/570743 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12746 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247999.pdf [firstpage_image] =>[orig_patent_app_number] => 11570743 [rel_patent_id] =>[rel_patent_doc_number] =>)